Effects of blood pressure lowering according to baseline cardiovascular disease: systematic review and meta-analysis of randomized trials

Back

ESC Professional Premium Access

Effects of blood pressure lowering according to baseline cardiovascular disease: systematic review and meta-analysis of randomized trials

Session: Drugs and devices in hypertension

Topic: Pharmacotherapy

Speaker: Mrs E. Manta (Athens, GR)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Mrs Eleni Manta

Ippokrateio General Hospital of Athens, Athens (Greece)

0 follower

7 more presentations in this session

The safety and efficacy of quadruple ultra-low-dose combination (quadpill) for hypertension treatment: a meta-analysis of randomized controlled trials

Speaker: Doctor M. Ibrahim (Flint, US)

Efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in essential hypertension

Speaker: Professor J. Wang (Shanghai, CN)

Comparing cardiovascular outcomes and costs of perindopril-, enalapril- or losartan-based antihypertensive regimens in South Africa: real-world medical claims database analysis

Speaker: Professor N. Ntusi (Cape Town, ZA)

Neuroprotective efficacy of combined antihypertensive treatment with the inclusion of nitrendipine in patients with arterial hypertension

Speaker: Associate Professor G. Abdullaeva (Tashkent, UZ)

Improved health-related quality of life after renal denervation in patients with resistant hypertension: 3-year outcomes in the global symplicity registry

Speaker: Associate Professor F. Mahfoud (Homburg, DE)

Access

Abstract

Slides

Access the full session

Drugs and devices in hypertension

Speakers: Mrs E. Manta, Doctor M. Ibrahim, Professor J. Wang, Professor N. Ntusi, Associate Professor G. Abdullaeva...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Effects of blood pressure lowering according to baseline cardiovascular disease: systematic review and meta-analysis of randomized trials

About the speaker

Mrs Eleni Manta

7 more presentations in this session

The safety and efficacy of quadruple ultra-low-dose combination (quadpill) for hypertension treatment: a meta-analysis of randomized controlled trials

Efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in essential hypertension

Comparing cardiovascular outcomes and costs of perindopril-, enalapril- or losartan-based antihypertensive regimens in South Africa: real-world medical claims database analysis

Neuroprotective efficacy of combined antihypertensive treatment with the inclusion of nitrendipine in patients with arterial hypertension

Improved health-related quality of life after renal denervation in patients with resistant hypertension: 3-year outcomes in the global symplicity registry

Access the full session

Drugs and devices in hypertension

About the event

ESC Congress 2023

ESC 365 is supported by